DocuSign
DOCU
68.90
+0.68
+1.00%
DocuSign
US · DOCU
#1274 by market cap
Listed 2018
68.90
+0.68
+1.00%
Live - 5344 symbols - heartbeat 156s ago
· 2026-10-08 08:25
Pre-market
68.94
+0.06%
After-hours
68.90
0.00%
Overnight
68.90
0.00%
- Market cap
- 12.88B
- P/E (TTM)i
- 42.01
- P/Bi
- 7.49
- EPSi
- 1.48
- Div yieldi
- 0.00%
- 52W posi
- 82%
Reader sentiment
Are you bullish or bearish on DOCU?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.57, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +8.16% YoY
Margins
- Gross margin
- 79.40%
- Operating margin
- 9.27%
- Net margin
- 9.60%
Key ratios & quality
- Altman Z-Scorei
- 3.57
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 700.97M | 973.97M | 1.45B | 2.11B | 2.52B | 2.76B | 2.98B | 3.22B |
| Gross profit | 508.55M | 730.74M | 1.09B | 1.64B | 1.98B | 2.19B | 2.36B | 2.56B |
| Selling & admin expenses | 748.90M | 738.69M | 991.32M | 1.31B | 1.56B | 1.59B | 1.54B | 1.59B |
| Research & development | 185.97M | 185.55M | 271.52M | 393.36M | 480.58M | 539.49M | 588.46M | 664.99M |
| Operating profit | -426.32M | -193.51M | -173.86M | -61.88M | -59.70M | 62.02M | 229.65M | 298.58M |
| Pretax profit | -428.21M | -203.56M | -229.49M | -66.91M | -89.88M | 93.68M | 247.94M | 347.33M |
| Tax | -1.75M | 4.80M | 13.78M | 3.06M | 7.57M | 19.70M | -819.94M | 38.24M |
| Net profit | -426.46M | -208.36M | -243.27M | -69.98M | -97.45M | 73.98M | 1.07B | 309.09M |
| Basic EPS | -3 | -1 | -1 | 0 | 0 | 0 | 5 | 2 |
| Diluted EPS | -3.16 | -1.18 | -1.31 | -0.36 | -0.49 | 0.36 | 5.08 | 1.48 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 763.65M | 800.64M | 818.35M | 836.86M | 830.24M | 875.75M |
| Gross profit | 606.39M | 635.17M | 647.80M | 667.08M | 658.97M | 697.87M |
| Selling & admin expenses | 386.68M | 400.32M | 394.82M | 411.05M | 388.07M | 416.67M |
| Research & development | 159.45M | 169.63M | 167.63M | 168.28M | 159.59M | 163.58M |
| Operating profit | 60.26M | 65.23M | 85.36M | 87.74M | 111.31M | 117.62M |
| Pretax profit | 73.79M | 76.46M | 95.53M | 101.55M | 117.76M | 124.98M |
| Tax | 1.70M | 13.49M | 11.80M | 11.25M | 39.56M | 47.26M |
| Net profit | 72.09M | 62.97M | 83.73M | 90.30M | 78.20M | 77.72M |
| Basic EPS | 0 | 0 | 0 | 0 | 0 | 0 |
| Diluted EPS | 0.34 | 0.30 | 0.40 | 0.44 | 0.40 | 0.40 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 984.52M | 943.89M | 1.16B | 1.32B | 1.63B | 1.57B | 1.49B | 1.49B |
| Cash & ST investments | 769.01M | 656.14M | 773.51M | 802.82M | 1.03B | 1.05B | 963.55M | 866.53M |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 1.62B | 1.89B | 2.34B | 2.54B | 3.01B | 2.97B | 4.01B | 4.23B |
| Total current liabilities | 516.31M | 693.97M | 1.09B | 1.37B | 2.21B | 1.66B | 1.83B | 2.04B |
| Short-term debt | -- | 20.73M | 53.44M | 37.40M | 746.94M | 22.23M | 19.08M | 16.62M |
| Long-term debt | 438.93M | 465.32M | 696.61M | 718.49M | -- | -- | -- | -- |
| Total liabilities | 1,001,055,000.00 | 1,344,811,000.00 | 2,010,770,000.00 | 2,265,762,000.00 | 2,395,433,000.00 | 1,841,551,000.00 | 2,010,013,000.00 | 2,311,730,000.00 |
| Total equity | 614.36M | 546.33M | 325.74M | 275.50M | 617.29M | 1.13B | 2.00B | 1.92B |
| Retained earnings | -928.78M | -1.14B | -1.38B | -1.44B | -1.60B | -1.67B | -1.29B | -1.86B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 1.38B | 1.32B | 1.31B | 1.49B | 1.26B | 1.27B |
| Cash & ST investments | 948.69M | 844.46M | 839.87M | 866.53M | 814.18M | 777.68M |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 3.95B | 3.95B | 3.98B | 4.23B | 3.98B | 3.96B |
| Total current liabilities | 1.74B | 1.78B | 1.78B | 2.04B | 1.89B | 1.97B |
| Short-term debt | 21.82M | 21.19M | 15.84M | 16.62M | 16.06M | 15.52M |
| Long-term debt | -- | -- | -- | -- | -- | -- |
| Total liabilities | 1,932,601,000.00 | 1,961,948,000.00 | 2,000,518,000.00 | 2,311,730,000.00 | 2,164,257,000.00 | 2,242,270,000.00 |
| Total equity | 2.01B | 1.99B | 1.98B | 1.92B | 1.82B | 1.72B |
| Retained earnings | -1.40B | -1.54B | -1.67B | -1.86B | -2.10B | -2.33B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 76.09M | 115.70M | 296.95M | 506.47M | 506.76M | 979.53M | 1.02B | 1.17B |
| Depreciation & amortization | 38.03M | 50.18M | 71.09M | 81.91M | 86.26M | 95.06M | 107.80M | 116.08M |
| Free cash flow | 45.67M | 43.65M | 214.56M | 445.07M | 429.11M | 887.14M | 920.28M | 1.06B |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 529.31M | -- | 0 | 0 | -63.04M | -145.52M | -683.53M | -869.09M |
| Ending cash balance | 518.18M | 241.48M | 566.34M | 509.68M | 723.20M | 801.50M | 659.55M | 618.15M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 251.44M | 246.07M | 290.27M | 377.22M | 321.69M | 334.55M |
| Depreciation & amortization | 30.37M | 28.88M | 30.40M | 26.43M | 32.21M | 33.79M |
| Free cash flow | 227.82M | 217.65M | 262.90M | 350.20M | 289.44M | 295.76M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -183.43M | -201.51M | -215.06M | -269.08M | -317.51M | -306.52M |
| Ending cash balance | 672.48M | 616.29M | 600.27M | 618.15M | 565.70M | 545.50M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -103.55 | -35.90 | -55.79 | -23.28 | -21.83 | 8.47 | 68.18 | 15.77 |
| ROA %i | -38.16 | -11.88 | -11.51 | -2.87 | -3.51 | 2.47 | 30.58 | 7.50 |
| ROIC %i | -49.91 | -17.66 | -18.72 | -5.50 | -7.21 | 1.80 | 60.59 | 12.56 |
| 5-year avg ROE %i | -- | -- | -- | -- | -89.23 | -25.67 | -4.85 | 9.46 |
| EBIT margin %i | -59.54 | -18.10 | -13.83 | -2.87 | -3.32 | 3.64 | 8.38 | 10.87 |
| FCF / sales %i | 6.52 | 4.48 | 14.77 | 21.12 | 17.06 | 32.12 | 30.92 | 32.88 |
| Current ratioi | 1.91 | 1.36 | 1.06 | 0.96 | 0.74 | 0.94 | 0.81 | 0.73 |
| Quick ratioi | 1.85 | 1.31 | 1.02 | 0.92 | 0.71 | 0.90 | 0.77 | 0.68 |
| Debt / assetsi | 27.17 | 34.29 | 39.19 | 34.72 | 29.48 | 4.81 | 3.10 | 4.38 |
| LT debt / equityi | 71.45 | 114.90 | 264.73 | 306.65 | 22.90 | 10.69 | 5.26 | 8.79 |
| Interest coveragei | -38.49 | -6.46 | -7.02 | -9.39 | -13.07 | 14.69 | 160.96 | 137.42 |
| Revenue CAGR (3Y) %i | 40.92 | 36.68 | 40.99 | 44.32 | 37.21 | 23.87 | 12.20 | 8.57 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | 81.22 | 113.59 | 114.22 | 60.50 | 27.40 | 35.12 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 70.20 | 14.23 | 15.22 | 15.77 | 16.44 | 17.80 |
| ROA %i | 32.19 | 7.29 | 7.80 | 7.50 | 7.95 | 8.34 |
| ROIC %i | 62.44 | 11.28 | 12.30 | 12.56 | 13.57 | 15.02 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 9.47 | 9.43 | 10.00 | 10.87 | 11.99 | 13.16 |
| FCF / sales %i | 30.22 | 30.23 | 31.27 | 32.88 | 34.09 | 35.65 |
| Current ratioi | 0.79 | 0.74 | 0.73 | 0.73 | 0.66 | 0.64 |
| Quick ratioi | 0.73 | 0.68 | 0.67 | 0.68 | 0.59 | 0.59 |
| Debt / assetsi | 3.37 | 3.21 | 3.78 | 4.38 | 4.60 | 4.62 |
| LT debt / equityi | 5.52 | 5.32 | 6.79 | 8.79 | 9.19 | 9.75 |
| Interest coveragei | 152.35 | 134.63 | 133.91 | 137.42 | 150.41 | 187.36 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 08:25:22 · For reference only, not investment advice and not tailored to your situation.